Table 2.
Physiological functions and causes of abnormal expression patterns of potential protein targets in various diseases.
| Target protein | Physiological function | Abnormal expression | Disease |
|---|---|---|---|
| KRAS | Signal transduction | Mutation | Pancreatic cancer, colorectal cancer, non-small cell lung cancer, etc. |
| p53 | Transcription | Mutation | Lung cancer, stomach cancer, liver cancer, etc. |
| C-MYC | Transcription | Overexpression | Lung cancer, stomach cancer, breast cancer, etc. |
| STAT3 | Transcription | Overexpression | Rectal cancer, lung cancer, breast cancer, etc. |
| AR-V7 | Transcription | Overexpression | Metastatic castration-resistant prostate cancer |
| β-catenin | Transcription | Abnormal accumulation | Colon cancer, hepatocellular carcinoma, pancreatic cancer, etc. |
| HOXA9 | Transcription | Overexpression | Acute myeloid leukemia |
| MEIS1 | Transcription | Overexpression | Acute myeloid leukemia |
| EWS-FLI1 | / | Fusion | Ewing sarcoma |
| PTP | Post-translation modification | Elevated/reduced expression | Breast cancer, stomach cancer, prostate cancer, rheumatoid arthritis, systemic lupus erythematosus, etc. |
| HAT | Post-translation modification | Mutation | Leukemogenesis, Rubinstein-Taybi syndrome, etc. |
| SMARCA2 | Chromatin remodelling | / | Non-small cell lung cancer, etc. |